| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/12/2006 | CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 07/12/2006 | CN1802366A C-glycoside derivatives and salts thereof |
| 07/12/2006 | CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
| 07/12/2006 | CN1264153C 光记录介质 The optical recording medium |
| 07/12/2006 | CN1263753C Method for synthetizing orixine and RU-19110 intermediate |
| 07/12/2006 | CN1263748C A process for the preparation of bis-benzazolyl compounds |
| 07/12/2006 | CN1263746C Pyridazinone derivatives |
| 07/12/2006 | CN1263728C Oxyalkylene-substituted aminophenol intermediate |
| 07/12/2006 | CN1263514C Fluoro labeled anthracyclinone and anthracycline derivatives |
| 07/11/2006 | US7074943 an oxygen-containing heterocyclic group F annelated on the i, j, or k side of the naphthopyran ring, having certain substituents at the 2, 5, and 6 positions of the naphthopyran ring; for ophthalmic lenses or other plastic transparencies that incorporate the naphthopyran compounds |
| 07/11/2006 | US7074940 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms |
| 07/11/2006 | US7074933 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
| 07/11/2006 | US7074920 Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 07/11/2006 | US7074826 R-NSAID esters and their use |
| 07/11/2006 | US7074821 Taxoids, their preparation and pharmaceutical composition containing them |
| 07/11/2006 | US7074819 Benzopyran or thiobenzopyran derivatives |
| 07/11/2006 | US7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| 07/11/2006 | US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity. |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074789 Kinase inhibitors |
| 07/11/2006 | US7074785 Δ1-pyrrolines used as pesticides |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2274074C Novel compounds with analgesic effect |
| 07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| 07/11/2006 | CA2257204C Processes for producing phenoxy propionic acid derivatives |
| 07/11/2006 | CA2244870C N,n-disubstituted amic acid derivatives |
| 07/11/2006 | CA2208630C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
| 07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/11/2006 | CA2035972C Process for the preparation of oxetanones |
| 07/06/2006 | WO2006071750A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders |
| 07/06/2006 | WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound |
| 07/06/2006 | WO2006070001A1 Substituted indole ligands for the orl-1 receptor |
| 07/06/2006 | WO2006069788A1 Organic compounds |
| 07/06/2006 | WO2006069775A1 5-ht7 receptor antagonists |
| 07/06/2006 | WO2006069525A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof |
| 07/06/2006 | WO2006052893A3 Substituted pyrrolidone compounds as ep4 agonists |
| 07/06/2006 | WO2006050389A3 Pyridazine compounds, compositions and methods |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060149069 2-Aminoprotected pyridine derivative is cyclized under heating to 5,6,7,8-tetrahydro-9H-pyrido[2,3-b]azepine or 1,2,3,4-tetrahydro-1,8-naphthyridine derivative; chemical intermediates; deblocking, deprotecting |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060148881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-Benzodioxan |
| 07/06/2006 | US20060148876 Nr3b1 nuclear receptor binding 3-substituted pyrazoles |
| 07/06/2006 | US20060148872 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one |
| 07/06/2006 | US20060148870 Process for preparing olmesartan medoxomil AT pH higher than 2.5 |
| 07/06/2006 | US20060148865 Preparation of chemical compounds |
| 07/06/2006 | US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/06/2006 | US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148820 Chroman derivatives and uses thereof |
| 07/06/2006 | US20060148817 Pyrazole compounds |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148780 Diazepanes derivatives useful as ifa inhibitors |
| 07/06/2006 | US20060147948 bioassay with compounds having dimaleimide groups attached directly to fluorescent cores, whose latent fluorescence is quenched until maleimide groups undergo thiol addition reaction, for detecting target proteins having sterically unhindered sulfhydryl groups; fluorescence resonance energy transfer |
| 07/06/2006 | US20060147827 Polymeric charge transport compound that is formed by reacting a functionality in a polymeric binder and an epoxy group contained in a hydrazone compound that also contains a diarylamine group, e.g., p-(Diphenylamino)benzaldehyde-N-2,3-epoxypropyl-N-Phenylhydrazone |
| 07/06/2006 | DE102004063227A1 Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tri-cyclic amino alcohols, processes for their preparation and their use as anti-inflammatories |
| 07/06/2006 | CA2594264A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders |
| 07/06/2006 | CA2591201A1 5-ht7 receptor antagonists |
| 07/06/2006 | CA2590586A1 Substituted biaryl analogues |
| 07/06/2006 | CA2587348A1 Organic compounds |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676840A1 5-HT7 Receptor antagonists |
| 07/05/2006 | EP1675838A1 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 07/05/2006 | EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 07/05/2006 | EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/05/2006 | EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | CN1798735A 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
| 07/05/2006 | CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases |
| 07/05/2006 | CN1798557A Antidepressants or food and drinks for antidepression |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/04/2006 | US7071359 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 07/04/2006 | US7071338 Process for the synthesis of bis-aryl diamidoxime compounds |
| 07/04/2006 | US7071337 Anticancer agents |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071216 Anticancer agents |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 07/04/2006 | US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2200579C Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives as colon motility enhancing agents |
| 06/29/2006 | WO2006069275A1 Tricyclic delta-opioid modulators |